Log in to save to my catalogue

Novel mannich-based derivative of 2-mercaptobenzimidazole (AK7): a new candidate for the treatment o...

Novel mannich-based derivative of 2-mercaptobenzimidazole (AK7): a new candidate for the treatment o...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2754047026

Novel mannich-based derivative of 2-mercaptobenzimidazole (AK7): a new candidate for the treatment of inflammatory arthritis owing to its NF-κB1 inhibitory potential

About this item

Full title

Novel mannich-based derivative of 2-mercaptobenzimidazole (AK7): a new candidate for the treatment of inflammatory arthritis owing to its NF-κB1 inhibitory potential

Publisher

Germany

Journal title

Naunyn-Schmiedeberg's archives of pharmacology, 2023-04, Vol.396 (4), p.811

Language

English

Formats

Publication information

Publisher

Germany

More information

Scope and Contents

Contents

This study investigated the anti-arthritic potential of novel mannich-based derivatives of 2-mercaptobenzimidazole (AK7 and AK9) in rats. The compounds were characterized by NMR and FTIR spectroscopies and their acute anti-inflammatory effects were measured by carrageenan (CRG)-induced paw edema model. The most potent doses of AK7 and AK9 were subs...

Alternative Titles

Full title

Novel mannich-based derivative of 2-mercaptobenzimidazole (AK7): a new candidate for the treatment of inflammatory arthritis owing to its NF-κB1 inhibitory potential

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2754047026

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2754047026

Other Identifiers

ISSN

1432-1912

E-ISSN

1432-1912

DOI

10.1007/s00210-022-02359-4

How to access this item